Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
absorption, abuse, abusive, AKS, Albany, Alstodt, arsenal, banker, Biochem, Biogen, Bioscience, Bipartisan, Boston, breadth, breakthrough, Brigham, Broadrick, Budget, cap, charitable, Chase, choose, Christopher, complicating, Congressional, construct, count, Curative, cure, Dale, degeneration, derecognition, Dermstadt, detain, developmental, dosage, Eagle, ECO, efficient, EMD, entrepreneurial, ENZ, Enzo, excretion, Fast, faster, foot, forfeited, formulary, frequency, Geduld, Gerard, Germany, GLP, GMP, Harvey, Harvinder, Head, Hofstra, Idec, immunohematology, incentive, indeterminable, inhibit, input, Inspector, intentional, interviewed, irreversible, Jason, Jersey, Justice, KGaA, lab, Lance, larger, Lerrink, lessee, leveraged, Lipetz, lumbosacral, Lynch, Malanga, MBA, meaningful, meant, MedVest, Melody, Merrill, MFN, Millennium, mirrored, misconduct, Mitigation, molecule, morbidity, Morgan, mortality, MossRehab, narrative, narrow, narrower, neurodegenerative, Neurotrope, nonemployee, Northwell, NYSE, Offshore, Oppenheimer, optimistic, orchestrated, orthopedic, overlap, Paccasassi, payer, penalty, Penn, percent, Physiatrist, PPACA, preliminary, prescribe, prevalence, proactive, Programhave, Programwere, proposition, rarity, reclassification, recognizable, recommend, recomputed, referral, Rhode, rolling, sampling, Sandhu, SCG, seize, sequencing, Serono, Sound, spent, Steven, strict, sum, supplement, supplemental, Surgeon, surveillance, switched, Task, Taxpayer, Technologist, theJournal, thirty, tolerable, tolerance, unacceptably, unanticipated, undiscounted, unfavorably, unmanaged, unmet, unrealized, unused, unvested, vii, viii, voluntary, Women, Young
Removed:
accessed, administer, aggregating, bagel, Big, broadened, called, capability, cGCP, chain, clinician, commented, contractor, Cooperation, Council, CSH, declaring, disqualification, EDPAB, electronic, factor, format, founded, fourth, franchised, Gene, gesture, Gesturetek, hereof, impermissibly, inactive, incubator, inside, interactive, interpretation, interstate, introducing, Israel, Jestertek, judicial, kind, label, mailed, mandate, markdown, markup, merger, month, nonclinical, notified, NYEPI, NYS, ofStem, originally, paying, payor, PCT, pioneering, procurement, prohibited, redirected, residence, restitution, retaining, safeguarding, secure, shipped, Simplification, skincare, spend, subcontractor, sufficiently, thawed, theAdministrative, theSecurity, transferred, transmitting, Treaty, upscale, utilized, video
Filing tables
Filing exhibits
- 10-K Annual report
- 10.5 EX-10.5
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.40 EX-10.40
- 10.56 EX-10.56
- 10.77 EX-10.77
- 10.83 EX-10.83
- 10.84 EX-10.84
- 10.85 EX-10.85
- 10.86 EX-10.86
- 10.93 EX-10.93
- 10.94 EX-10.94
- 10.95 EX-10.95
- 10.96 EX-10.96
- 10.97 EX-10.97
- 10.98 EX-10.98
- 10.99 EX-10.99
- 10.100 EX-10.100
- 10.102 EX-10.102
- 21 EX-21
- 23 EX-23
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32 EX-32
- Download Excel data file
- View Excel data file
BRTX similar filings
Filing view
External links
Exhibit 10.13
BioRestorative Therapies, Inc.
40 Marcus Drive, Suite One
Melville, New York 11747
| January 5, 2018 |
Mr. Francisco Silva
10 Flyers Lane
Tustin, California 92782
Dear Mr. Silva:
Reference is made to the Amended and Restated Executive Employment Agreement, dated as of May 10, 2011, between BioRestorative Therapies, Inc. (formerly known as Stem Cell Assurance, Inc.) and Francisco Silva, as amended (the “Employment Agreement”).
The parties hereby agree that, effective as of January 1, 2018, the “Per Annum Salary” in Schedule A of the Employment Agreement is amended to read as follows:
“Per Annum Salary: $287,500”
Except as amended hereby, the Employment Agreement shall continue in full force and effect in accordance with its terms.
| Very truly yours, | ||
| BioRestorative Therapies, Inc. | ||
| By: | ||
| Mark Weinreb, Chief Executive Officer | ||
| Agreed: | ||
| Francisco Silva | ||